In view of the known role of the PPP in cellular redox balance and the importance of ROS generation in chemotherapeutic response, we investigated whether targeting G6PD in bone metastatic prostate cancer cells could influence redox homeostasis and chemotherapy response. The gene discussed is G6PD; the disease is Familial prostate cancer.